These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35308026)

  • 21. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
    Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
    Armenian P; Vo KT; Barr-Walker J; Lynch KL
    Neuropharmacology; 2018 May; 134(Pt A):121-132. PubMed ID: 29042317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor.
    Bosquez-Berger T; Gudorf JA; Kuntz CP; Desmond JA; Schlebach JP; VanNieuwenhze MS; Straiker A
    J Med Chem; 2023 Jul; 66(14):9466-9494. PubMed ID: 37437224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
    Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
    Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone.
    Kassick AJ; Allen HN; Yerneni SS; Pary F; Kovaliov M; Cheng C; Pravetoni M; Tomycz ND; Whiting DM; Nelson TL; Feasel M; Campbell PG; Kolber B; Averick S
    ACS Appl Bio Mater; 2019 Aug; 2(8):3418-3428. PubMed ID: 31497753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.
    Moss RB; Pryor MM; Baillie R; Kudrycki K; Friedrich C; Reed M; Carlo DJ
    PLoS One; 2020; 15(6):e0234683. PubMed ID: 32544184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl.
    Bilel S; Azevedo Neto J; Arfè R; Tirri M; Gaudio RM; Fantinati A; Bernardi T; Boccuto F; Marchetti B; Corli G; Serpelloni G; De-Giorgio F; Malfacini D; Trapella C; Calo' G; Marti M
    Neuropharmacology; 2022 May; 209():109020. PubMed ID: 35247453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing the Fentanyl Analogue Epidemic by Multiplex UHPLC-MS/MS Analysis of Whole Blood.
    Bergh MS; Bogen IL; Wilson SR; Øiestad ÅML
    Ther Drug Monit; 2018 Dec; 40(6):738-748. PubMed ID: 30157097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Kinetics Relationships of Opioids from Metadynamics and Machine Learning Analysis.
    Mahinthichaichan P; Liu R; Vo QN; Ellis CR; Stavitskaya L; Shen J
    J Chem Inf Model; 2023 Apr; 63(7):2196-2206. PubMed ID: 36977188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest.
    Laffont CM; Purohit P; Delcamp N; Gonzalez-Garcia I; Skolnick P
    Front Psychiatry; 2024; 15():1399803. PubMed ID: 38952632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis.
    Baumann MH; Kopajtic TA; Madras BK
    Trends Pharmacol Sci; 2018 Dec; 39(12):995-998. PubMed ID: 30454770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
    Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
    Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice.
    Madison CA; Arora M; Kumar MNVR; Eitan S
    ACS Chem Neurosci; 2020 Jul; 11(13):1955-1964. PubMed ID: 32491828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of "Nitazene" 2-Benzylbenzimidazole Synthetic Opioids.
    Vandeputte MM; Van Uytfanghe K; Layle NK; St Germaine DM; Iula DM; Stove CP
    ACS Chem Neurosci; 2021 Apr; 12(7):1241-1251. PubMed ID: 33759494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders.
    Pagare PP; Flammia R; Zhang Y
    Pharmacol Res; 2024 Jan; 199():107023. PubMed ID: 38081336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fentanyl depression of respiration: Comparison with heroin and morphine.
    Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
    Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.